Atsushi Numabe

Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease

Atsuko Kamijo, Takeshi Sugaya, Akihisa Hikawa et al. · Molecular and Cellular Biochemistry · 2006 · 181 citations

Metabolic Syndrome, Urology, Renal Disease +14

Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development

Rie Hakamada‐Taguchi, Yoshio Uehara, Kagemasa Kuribayashi et al. · Circulation Research · 2003 · 171 citations

Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: A multicenter trial

Atsuko Kamijo, Takeshi Sugaya, Akihisa Hikawa et al. · Journal of Laboratory and Clinical Medicine · 2005 · 119 citations

Metabolic Syndrome, Renal Function, Renal Disease +11

Long-Term Inhibition of Renin-Angiotensin System Sustains Memory Function in Aged Dahl Rats

Nobuhito Hirawa, Yoshio Uehara, Yukari Kawabata et al. · Hypertension · 1999 · 63 citations · Full text

Hypertension, Aging, Receptor Antagonist +20

Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension

Toshihiko Ishimitsu, Atsushi Numabe, Toshihide Masuda et al. · Hypertension Research · 2009 · 60 citations · Full text

Molecular Pharmacology, Hypertension, Angiotensin-ii Receptor Antagonist +10